Exposure Therapy for Late-life Anxiety

Recruiting N/A Interventional Study
Anxiety Disorders Anxiety Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
170 (estimated)
Sponsor
ProPersona · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary objective is to evaluate the (cost-)effectiveness of exposure therapy (ET) delivered by trained mental health nurses (MHNs) in terms of anxiety symptoms and quality of life for late life anxiety disorders in primary care compared to usual care (UC). UC is not restricted, and the general practitioner (GP) is encouraged to work according to the guidelines of the Dutch College of GPs. P…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A primary DSM-5 anxiety disorder using the Mini Internationaal Neuropsychiatrisch Interview (MINI). * One of the following DSM-5 anxiety disorders will be diagnosed, Generalized Anxiety Disorder, Agoraphobia, Panic Disorder or Social Anxiety Disorder. * Participants are requir…
Contacts

Gert-Jan Hendriks, Professor

+31510038897

g.hendriks@propersona.nl

CONTACT

Nessa Ikani, Asst. Prof.

n.ikani@tilburguniversity.edu

CONTACT